AU Patent

AU2013295035B2 — Glucagon analogues

Assigned to Zealand Pharma AS · Expires 2017-08-03 · 9y expired

What this patent protects

The present invention relates to glucagon analogues and their medical use, for example in the treatment of hypoglycaemia. In particular, the present invention relates to stable glucagon analogues suitable for use in a liquid formulation.

USPTO Abstract

The present invention relates to glucagon analogues and their medical use, for example in the treatment of hypoglycaemia. In particular, the present invention relates to stable glucagon analogues suitable for use in a liquid formulation.

Drugs covered by this patent

dasiglucagon-hydrochloride (DASIGLUCAGON HYDROCHLORIDE)

Patent Metadata

Patent number: AU2013295035B2
Jurisdiction: AU
Classification: —
Expires: 2017-08-03
Drug substance claim: No
Drug product claim: No
Assignee: Zealand Pharma AS
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.